Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase NA 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 3Gastrointestinal 3Plasma cell 2Head & Neck 2Breast 2

Conditions

Breast Neoplasms 2Peripheral Nervous System Diseases 1Depression 1Anxiety Disorders 1Acute Pain 1

Interventions

Trastuzumab 349Paclitaxel 310Cyclophosphamide 286Docetaxel 267Carboplatin 215Capecitabine 215Letrozole 185Fulvestrant 178Doxorubicin 166Bevacizumab 136Anastrozole 120Tamoxifen 117pertuzumab 114pembrolizumab 113Epirubicin 110exemestane 107Vinorelbine 106Gemcitabine 106Albumin-Bound Paclitaxel 92Lapatinib 84130-nm albumin-bound paclitaxel 83Radiotherapy 79palbociclib 75eribulin 73Cisplatin 69pyrotinib 66Taxes 65Everolimus 55Goserelin 50Drug Therapy 50

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Minocycline × Breast × Clear all
NCT02203552 2025-01-08

Minocycline Hydrochloride in Reducing Chemotherapy Induced Depression and Anxiety in Patients With Stage I-III Breast Cancer

Ohio State University Comprehensive Cancer Center

Phase 2 Completed
56 enrolled 9 charts
Breast

Anxiety Disorders, Breast Neoplasms, Depression

NCT02297412 2022-01-31

Minocycline Hydrochloride in Reducing Chemotherapy-Induced Peripheral Neuropathy and Acute Pain in Patients With Breast Cancer Undergoing Treatment With Paclitaxel

Academic and Community Cancer Research United

Phase 2 Completed
47 enrolled 9 charts
Breast

Breast Neoplasms, Peripheral Nervous System Diseases, Acute Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡